Short- and long-term glycemic effects of pasireotide in patients with acromegaly: a comprehensive case study with review of literature

Short- and long-term glycemic effects of pasireotide in patients with acromegaly: a comprehensive case study with review of literature

Pasireotide (PAS), a multireceptor somatostatin analog, has been demonstrated to effectively control hormone levels, including those of growth hormone (GH) and insulin-like growth factor 1 (IGF-1), in patients with acromegaly. However, it induces hyperglycemia by inhibiting insulin secretion via som...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuki Taki, Takashi Kono, Tatsuma Matsuda, Ryunosuke Kozu, Masanori Fujimoto, Ikki Sakuma, Naoko Hashimoto, Kentaro Horiguchi, Yoshinori Higuchi, Tomoaki Tanaka
Format: Article
Language:English
Published: The Japan Endocrine Society 2025-04-01
Series:Endocrine Journal
Subjects:
acromegaly
pasireotide
continuous glucose monitoring (cgm)
glucagon-like peptide-1 receptor agonist (glp-1ra)
semaglutide
Online Access:https://www.jstage.jst.go.jp/article/endocrj/72/4/72_EJ24-0548/_html/-char/en
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.jstage.jst.go.jp/article/endocrj/72/4/72_EJ24-0548/_html/-char/en

Similar Items